We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-6.87%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$3.98B
AUM Growth
-$931M
Cap. Flow
-$600M
Cap. Flow %
-15.05%
Top 10 Hldgs %
60.92%
Holding
66
New
9
Increased
17
Reduced
15
Closed
22

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$71.2M
2
HUM icon
Humana
HUM
+$68.6M
3
CI icon
Cigna
CI
+$60.7M
4
UBER icon
Uber
UBER
+$57.6M
5
CNC icon
Centene
CNC
+$55.7M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$324M
2
DOCN icon
DigitalOcean
DOCN
+$111M
3
THC icon
Tenet Healthcare
THC
+$96.7M
4
EXPE icon
Expedia Group
EXPE
+$91.1M
5
KNX icon
Knight Transportation
KNX
+$76.3M

Sector Composition

Rank Sector Weight
1 Healthcare 45.27%
2 Technology 18.54%
3 Industrials 11.89%
4 Consumer Discretionary 9.84%
5 Communication Services 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FUN icon
26
Cedar Fair
FUN
$1.78B
$39.5M 0.99%
2,223,149
+1,100,775
+98% +$18.6M
GENI icon
27
Genius Sports
GENI
$1.73B
$37.9M 0.95%
8,560,888
+6,530,679
+322% +$46.5M
USFD icon
28
US Foods
USFD
$21.4B
$35.4M 0.89%
384,007
-753,756
-66% -$66.8M
Z icon
29
Zillow
Z
$7.04B
$32.7M 0.82%
789,670
-373,885
-32% -$19.9M
LAD icon
30
Lithia Motors
LAD
$7.78B
$31.9M 0.8%
127,605
– –
BLCO icon
31
Bausch + Lomb
BLCO
$5.77B
$30.4M 0.76%
1,910,496
+256,641
+16% +$4.36M
DHR icon
32
Danaher
DHR
$135B
$29.6M 0.74%
156,275
-43,916
-22% -$9.35M
LION icon
33
Lionsgate Studios
LION
$3.88B
$26.6M 0.67%
2,778,781
-4,728,019
-63% -$43.6M
CSCO icon
34
Cisco
CSCO
$450B
$26.4M 0.66%
+339,819
New +$26.6M
MYGN icon
35
Myriad Genetics
MYGN
$530M
$24.4M 0.61%
5,411,978
+824,571
+18% +$4.3M
SGRY icon
36
Surgery Partners
SGRY
$2.06B
$21.5M 0.54%
1,800,000
-2,058,088
-53% -$29.5M
DOCN icon
37
DigitalOcean
DOCN
$14.4B
$21.4M 0.54%
250,000
-1,754,299
-88% -$111M
BKR icon
38
Baker Hughes
BKR
$56.8B
$18.5M 0.47%
+303,675
New +$17.6M
AKAM icon
39
Akamai
AKAM
$16.8B
$18M 0.45%
+156,453
New +$15.7M
INTC icon
40
Intel
INTC
$466B
$17.6M 0.44%
+399,506
New +$18.3M
BIIB icon
41
Biogen
BIIB
$29.9B
$10.5M 0.26%
57,019
-233,586
-80% -$43M
PRMB
42
Primo Brands
PRMB
$8.24B
$10M 0.25%
+531,051
New +$10.3M
TECH icon
43
Bio-Techne
TECH
$11.2B
$9.74M 0.24%
186,312
-433,632
-70% -$26M
GPN icon
44
CALL
Global Payments
GPN
$22.1B
$6.73M 0.17%
+100,000
New +$7.38M
ACN icon
45
Accenture
ACN
$89.9B
– –
-191,326
Closed -$51.3M
AMBA icon
46
Ambarella
AMBA
$2.99B
– –
-100,000
Closed -$7.08M
BFLY.WS
47
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
– –
-1,713,333
Closed -$30.2K
CEG icon
48
Constellation Energy
CEG
$98B
– –
-30,412
Closed -$10.7M
CRM icon
49
CALL
Salesforce
CRM
$134B
– –
-83,800
Closed -$22.2M
DNA icon
50
Ginkgo Bioworks
DNA
$481M
– –
-149,379
Closed -$1.24M
1
2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Glenview Capital Management held 66 positions worth $3.98B, down 19% from $4.91B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Glenview Capital Management withdrew a net $600M in Q1 2026, closing 22 positions and reducing 15 holdings. Its most notable exit was Expedia Group, an estimated $91.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Humana worth $58.1M.

  • Glenview Capital Management's largest Q1 2026 buy was Humana: 334,892 shares worth $58.1M.
  • Glenview Capital Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $71.2M increase.
  • Glenview Capital Management's biggest Q1 2026 reduction was Teva Pharmaceuticals, cutting an estimated $324M.
  • Glenview Capital Management fully exited Expedia Group in Q1 2026, selling an estimated $91.1M.
  • Glenview Capital Management's ten largest holdings make up 61% of its $3.98B portfolio in Q1 2026.
  • Glenview Capital Management opened 9 new positions and closed 22 in Q1 2026.
  • Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $3.98B.

Based on Glenview Capital Management's 13F filing for Q1 2026, filed 15 May 2026.